Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+T cells

Details for Australian Patent Application No. 2009255999 (hide)

Owner Baylor Research Institute

Inventors Palucka, Anna Karolina; Banchereau, Jacques F.; Klechevsky, Eynav

Agent Pizzeys

Pub. Number AU-A-2009255999

PCT Pub. Number WO2009/149382

Priority 61/059,647 06.06.08 US

Filing date 5 June 2009

Wipo publication date 10 December 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/149382 Priority application(s): WO2009/149382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256007-A system and method for cosmetic treatment and imaging

2009255994-Use of pegylated Type III Interferons for the treatment of hepatitis C